Daily News Podcast

Antibody cleared amyloid plaques, slowed cognitive decline


 

An experimental agent slowed cognitive decline and cleared Alzheimer’s plaques. Can meteorology predict migraines? Why closing a patent foramen ovale is the right approach to prevent recurring ischemic stroke. And claims that cannabis relieves noncancer pain go up in smoke.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

New studies expand on Aimovig for migraine
MDedge Family Medicine
How to prescribe effectively for opioid use disorder
MDedge Family Medicine
Is fish oil’s heart benefit a fish tale?
MDedge Family Medicine
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
MDedge Family Medicine
Weather changes trigger migraine
MDedge Family Medicine
Pseudotumor cerebri pediatric rates are rising
MDedge Family Medicine
Guideline: PFO closure best bet for recurrent stroke prevention
MDedge Family Medicine
Monoclonal antibody slowed cognitive decline, cleared Alzheimer’s plaques in phase 2 trial
MDedge Family Medicine
Blood pressure meds cut cognitive impairment risk
MDedge Family Medicine
Alzheimer’s trial design problem throws a wrench in promising BAN2401 results
MDedge Family Medicine